Business Description
Bio-Techne Corp
NAICS : 325414
SIC : 2836
ISIN : US09073M1045
Compare
Compare
Traded in other countries / regions
TECH.USAT1CH34.BrazilTE1.GermanyTECH.Mexico IPO Date
2021-11-11Description
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.29 | |||||
| Equity-to-Asset | 0.74 | |||||
| Debt-to-Equity | 0.25 | |||||
| Debt-to-EBITDA | 1.38 | |||||
| Interest Coverage | 14.62 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 12.63 | |||||
| Beneish M-Score | -2.61 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 14.4 | |||||
| 3-Year EBITDA Growth Rate | 5.6 | |||||
| 3-Year EPS without NRI Growth Rate | 20.5 | |||||
| 3-Year FCF Growth Rate | 11.1 | |||||
| 3-Year Book Growth Rate | 11.6 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 5.56 | |||||
| Future 3-5Y Total Revenue Growth Rate | 6.81 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.08 | |||||
| Quick Ratio | 2.88 | |||||
| Cash Ratio | 0.97 | |||||
| Days Inventory | 169.07 | |||||
| Days Sales Outstanding | 67.97 | |||||
| Days Payable | 26.92 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.8 | |||||
| Shareholder Yield % | -0.2 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 66.8 | |||||
| Operating Margin % | 21.44 | |||||
| Net Margin % | 17.59 | |||||
| FCF Margin % | 21.75 | |||||
| ROE % | 10.32 | |||||
| ROA % | 7.55 | |||||
| ROIC % | 8.88 | |||||
| ROC (Joel Greenblatt) % | 38.62 | |||||
| ROCE % | 9.77 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 65.48 | |||||
| Forward PE Ratio | 41.89 | |||||
| PE Ratio without NRI | 44.84 | |||||
| Shiller PE Ratio | 69.79 | |||||
| Price-to-Owner-Earnings | 57.41 | |||||
| PEG Ratio | 2.79 | |||||
| PS Ratio | 11.52 | |||||
| PB Ratio | 6.45 | |||||
| Price-to-Tangible-Book | 25.15 | |||||
| Price-to-Free-Cash-Flow | 52.92 | |||||
| Price-to-Operating-Cash-Flow | 43.31 | |||||
| EV-to-EBIT | 53.56 | |||||
| EV-to-Forward-EBIT | 48.5 | |||||
| EV-to-EBITDA | 37.1 | |||||
| EV-to-Forward-EBITDA | 38.74 | |||||
| EV-to-Revenue | 11.57 | |||||
| EV-to-Forward-Revenue | 12.84 | |||||
| EV-to-FCF | 53.16 | |||||
| Price-to-Projected-FCF | 2.85 | |||||
| Price-to-DCF (Earnings Based) | 4.14 | |||||
| Price-to-DCF (FCF Based) | 6.13 | |||||
| Price-to-Median-PS-Value | 1.14 | |||||
| Price-to-Peter-Lynch-Fair-Value | 4.58 | |||||
| Price-to-Graham-Number | 7.08 | |||||
| Earnings Yield (Greenblatt) % | 1.87 | |||||
| FCF Yield % | 1.93 | |||||
| Forward Rate of Return (Yacktman) % | 11.53 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Bio-Techne Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil MXN) | 19,762.77 | ||
| EPS (TTM) (MXN) | 21.589 | ||
| Beta | 0 | ||
| Volatility % | 0.1 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR (MXN) | 0 | ||
| 20-Day SMA (MXN) | 2418.75 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (MXN) | 2418.75 - 2418.75 | ||
| Shares Outstanding (Mil) | 157.58 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Bio-Techne Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Bio-Techne Corp Stock Events
| Event | Date | Price(MXN) | ||
|---|---|---|---|---|
| No Event Data | ||||
Bio-Techne Corp Frequently Asked Questions
What is Bio-Techne Corp(MEX:TECH)'s stock price today?
The current price of MEX:TECH is MXN2418.75. The 52 week high of MEX:TECH is MXN2418.75 and 52 week low is MXN2418.75.
When is next earnings date of Bio-Techne Corp(MEX:TECH)?
The next earnings date of Bio-Techne Corp(MEX:TECH) is 2024-08-08 Est..
Does Bio-Techne Corp(MEX:TECH) pay dividends? If so, how much?
Bio-Techne Corp(MEX:TECH) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers